Several studies have shown that BC-derived EVs containing PD-L1 can induce an enhanced immunosuppressive phenotype in BC, impairing the activation and cancer killing potential of T cells and enhancing tumour growth [133,134,135]. This evidence concerns the gene CD274 and neoplasm.